Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 66.4 | 70.2 | 47.5 | 63.6 |
| Revenue growth | -5.4% | 47.7% | -25.2% | |
| Cost of goods sold | 33.0 | 33.9 | 23.4 | 28.8 |
| Gross profit | 33.5 | 36.3 | 24.1 | 34.8 |
| Gross margin | 50.4% | 51.7% | 50.7% | 54.7% |
| Sales and marketing | 9.8 | 9.2 | 7.5 | 8.8 |
| Research and development | 18.3 | 17.0 | | |
| General and administrative | 7.3 | 6.5 | 5.5 | 6.6 |
| EBITA | -1.7 | 4.0 | 0.2 | 7.2 |
| EBITA margin | -2.6% | 5.6% | 0.5% | 11.4% |
| Amortization of intangibles | 0.3 | 0.3 | 0.3 | 0.6 |
| EBIT | -2.0 | 3.7 | -0.1 | 6.6 |
| EBIT margin | -3.0% | 5.3% | -0.1% | 10.4% |
| Pre-tax income | -2.8 | 2.5 | -6.4 | 5.9 |
| Income taxes | -1.0 | 0.9 | -0.6 | 2.2 |
| Tax rate | 36.7% | 37.0% | 9.6% | 38.0% |
| Net income | -1.8 | 1.6 | -5.8 | 3.7 |
| Net margin | -2.6% | 2.3% | -12.3% | 5.8% |
| |
| Diluted EPS | ($0.06) | $0.06 | ($0.22) | $0.13 |
| Shares outstanding (diluted) | 30.3 | 28.2 | 26.8 | 27.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|